JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Hrring, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Hrring, D. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 103, Issue 2, 178-186, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


THE COMPARATIVE PHARMACOLOGY OF THE HYDROXY AND METHYL DERIVATIVES OF 6-METHYL-2-HEPTYLAMINE

David F. Marsh 1 and D. A. Hrring 1

1 Department of Pharmacology, West Virginia University School of Medicine, Morgantown, W. Va.

6-Methyl-2-heptylamine and 6-methyl-2-heptyl methylamine are approximately equipotent as moderately active sympathomimetic amines with the expected effects in man and animals. Introduction of a hydroxy group in the 6 position removes most of the apparent vasopressor activity, but leaves or enhances the myocardial stimulant activity. As determined with various experiments in man, dogs, cats, rabbits, and mice, the 6-hydroxy-6-methyl-2-heptylamine and 6-hydroxy-6-methyl-2-heptyl methylamine are orally active, produce increased force of myocardial contraction, increased heart rate that can be antagonized with veratramine, increased coronary flow, increased urine output, and possibly mild vasoconstriction. The corresponding 6-methoxy-6-methyl-2-heptyl methylamine is less active, and the 6-hydroxy-3,6-dimethyl-2-heptyl methylamine and 6-hydroxy-4,6-dimethyl-2-heptyl methylamine are essentially inactive.

Submitted on July 2, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.